InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
Making a Real Difference for Patients Living with Cancer
McKesson is uniquely positioned to advance cancer care.
Treating cancer is becoming increasingly complex. More than ever, oncologists need the right solutions and technologies to provide the best possible care to their patients.
At McKesson, our legacy of oncology innovation runs deep. We support an unparalleled network of oncology providers to give patients access to life-changing therapies. See how our patient-first approach and unparalleled suite of cancer offerings help enhance patients’ lives.
To learn more, visit: McKesson Oncology Solutions.
Related Stories
How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology. How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology.
Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.
By teaming up with Angels for Change, we’re helping patients navigate drug shortages and access lifesaving treatments.
Health Mart pharmacies play a key role in providing accessible flu and RSV vaccination services to communities nationwide.
A McKesson employee and cancer survivor’s story of resilience and the power of empathy.
Ontada is an oncology technology and insights company committed to advancing cancer research and care by connecting life sciences partners, providers and patients.
Discover how McKesson Amplify is strengthening the voice of pharmacy professionals nationwide by awarding funding to every eligible state pharmacy association across all 50 states.
Top insights from the Endpoints at ASCO McKesson leadership panel
Enhancing patient access and engagement in clinical trials.